Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-27

Clinical Trial Update: Ferumoxytol-enhanced Imaging and Mapping in neuroAIDS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on ferumoxytol-enhanced imaging and mapping in neuroAIDS; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FERUMOXYTOL (ferumoxytol)

Snippet

Sponsor: Beau Nakamoto | Conditions: AIDS Dementia Complex | Phase 2 | Status: COMPLETED